Fundz

Life Biosciences Receives Translational Research Funding From Alzheimer'S Drug Discovery Foundation

PRIVATESep 28, 2021

Round Type

Funding Round

BostonOtherBiotechnologyHealth Care

Description

Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced translational research funding from the Alzheimer's Drug Discovery Foundation (ADDF) to support the development of chaperone-mediated autophagy (CMA) activators for the treatment of Alzheimer's disease and other neurodegenerative diseases.

Quick answer

Life Biosciences raised an undisclosed amount in a Funding Round round, dated September 28, 2021. Life Biosciences is based in Boston, Massachusetts, United States.

How much did Life Biosciences raise?
Life Biosciences raised an undisclosed amount in a Funding Round round on September 28, 2021.
What does Life Biosciences do?
Life Bio is a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging.
Where is Life Biosciences based and how big is it?
Life Biosciences is based in Boston, Massachusetts, United States. Fundz records about 24 employees.
Who are the decision-makers at Life Biosciences?
Fundz holds 2 contacts at Life Biosciences, including the Associate Director, Molecular Biology & Gene Delivery. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Life Biosciences, and when

A new round usually means Life Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Life Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Life Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Life Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Life Biosciences

Location

Boston, Massachusetts, United States

About

Life Bio is a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. The company’s proprietary partial epigenetic reprogramming platform utilizes three transcription factors—Oct4, Sox2, and Klf4—to restore older and damaged cells to a younger state. This innovative approach targets a root cause of aging at the epigenetic level, thereby offering the potential to address a wide range of age-related diseases with significant unmet medical needs. Life Bio’s lead program, ER-100, is being developed as a gene therapy for optic neuropathies with plans to enter the clinic in 2025. Beyond ER-100, the company is strategically broadening its therapeutic pipeline to address additional age-related diseases, underscoring the platform’s versatility and transformative potential.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Life Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsYuan Y., Associate Director, Molecular Biology &…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Life Biosciences's next move

See what Strategic adds

Life Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.